First-line Latanoprost Therapy in Ocular Hypertension or Open-angle Glaucoma Patients: a 3-month Efficacy Analysis Stratified by Initial Intraocular Pressure
How effective is latanoprost in the treatment of both glaucoma and ocular hypertension?
BMC Ophthalmology
More Bad News for Rosiglitazone
Mounting evidence of adverse cardiovascular effects continues to erode justification for the use of rosiglitazone.
Journal Watch
Sanofi-Aventis Sues FDA Over Generic Lovenox Approval
The Lovenox manufacturer wants the FDA to reverse the approval decision it made last week, on grounds that the generic product is not clinically equivalent to its own product.
Heartwire
Daptomycin May Be Linked to Eosinophilic Pneumonia
In 7 cases reviewed by the FDA, patients developed eosinophilic pneumonia 2 to 4 weeks after starting daptomycin treatment.
Medscape Medical News